During the past 15 years, the number of colorectal cancer survivors has risen dramatically. While it is unclear how many colorectal cancer survivors were employed at the time of diagnosis, it is reasonable to expect a significant proportion of these survivors were temporarily displaced from the work force. This article describes the return to work experiences of 250 colorecta1 cancer survivors. The majority (80%) of the survivors were employed at diagnosis and 89% returned to work. Of those who returned to work, 81% sustained employment 5 years postdiagnosis. Results indicate survivors were successful in their attempt to return to work and sustain employment. However, 34% of survivors delayed their return beyond 2 months pestdiagnosis. After controlling for ethnicity, education, and disease severity, the reason for delay was related to chemotherapy treatment. Prospective studies of colorectal cancer survivors to document' barriers to work return can guide interventions and occupational services to keep survivors healthy and in the workplace.
C
Olorectal cancer mortality has been declining during the past IS years (American Cancer Society, 2(03). Advances in adjuvant therapy, the introduction of oral chemotherapy, and the promise of immunotherapy and gene therapy are expected to increase the number of individuals living with a history of colorectal cancer (Prabhudesal, 2(02). Recent Surveillance, Epidemiology, and End Results (SEER) data indicate colorectal cancer survivors represent the third largest cancer survivor group (12%) after breast (28%) and prostate cancer (14%) survivors (Rowland, 200 I) . While it is unclear how many of these colorectal cancer survivors were employed at the time of diagnosis, it is reasonable to expect that a significant proportion of these survivors were tempomrily displaced from the work force. As the number of cancer survivors increases, empirical data on their work experiences also is growing (Ashing-Giwa, 1997; Berry, 1993; Bradley, 2002; Bushunow, 1995; Chirikos, 2001 Chirikos, , 2002 Feldman, 1976 Feldman, , 1978 Greenleigh Associates, 1979; Greenwald, 1989; Maunsell, 1999; Meyerowitz, 1983; Razavi, 1993; Satariano, 1996; Schultz, 2002; Spelton, 2003; van der Wouden, 1992; Watson, 1990) . However, the majority of these studies have concentrated primarily on breast cancer or cancer survivors in general. The paucity of empirical data on the work experiences of colorectal cancer survivors (Bradley, 2002; Feldman, 1976 Feldman, , 1978 Schultz, 2002; Spelton, 2(03) warrants further investigation.
Research indicates work force participation in the United States peaks for individuals between the ages of 25 and 54 years (Fullerton, 1999) . However, recent economic trends indicate increased life expectancies have changed the composition of the working age population to include a sizable cohort of older workers (Riche, 2(01) . Thus, despite the fact that 90% of all individuals with colorectal cancer are diagnosed at age 50 or older, voluntary withdrawal (i.e., retirement) from the workplace may not necessarily be imminent. Work life for colorectal cancer survivors remains important as research suggests American workers accrue a substantial portion of their assets 10 years prior to retirement (Newton, 2003) . Finally, as national campaigns to promote colon and rectal cancer screening gain momentum, it is possible that early detection efforts to identify individuals will result in more colorectal cancer survivors facing the challenges of workplace reintegration.
WORK EXPERIENCES OF CANCER SURVIVORS
The ability to return to work has been linked with survival (Waxler-Morrison, I~9l), financial (Hoffman, 1999; Mellete, 1985) , and psychosocial well being (Feldman, 1976; National Cancer Institute News, 1998; Peteet, 2002) . Prior employment studies have shown between 44% and 88% of all cancer survivors return to work as productive employees (Berry, 1993; Bradley, 2002; Bushunow, 1995; Feldman, 1976 Feldman, , 1978 Greenleigh Associates, 1979; Greenwald, 1989; Schultz, 2002; Spelton, 2003; van derWouden, 1992) . Two classic studies by Feldman (1976 Feldman ( , 1978 have provided the most comprehensive information about the return to work experiences of colorectal cancer survivors. Although the study sample sizes were small in both studies (n =38 and n =24), the return to work rates were consistently high (74% and 75%). In a more recent study of colon cancer survivors, Schultz (2002) reported 67% of individuals with a history of colon cancer (n =95) reported working 5 years postdiagnosis.
In a review of 14 return to work studies, a variety of person (i.e., age), disease (i.e., treatment), and work related (i.e., physical workload) factors were associated with return to work (Spelton, 2002) . However, only 4 of the 14 studies concurrently examined personal and disease characteristics as well as characteristics of the work environment. Based on these four studies, person and disease related factors were negatively associated with return to work or showed no association at all, whereas the evidence of a relationship between person related factors and return to work was mixed. Work related factors (i.e., physical demands at work) consistently were negatively associated with return to work. In a longitudinal study of cancer survivors, Spelton (2003) found the strongest predictors of return to work were diagnosis, treatment, age, physical workload, physical complaints, and depression.
Return to work symbolizes a resumption of normal activities for cancer survivors and is a positive step toward recovery and rehabilitation. A delayed return to the workplace may impact wages, health benefits, family finances, and social relations in the workplace. Therefore, understanding the barriers that prevent survivors from returning to work as quickly as possible is important. The literature on the recovery time and employment of workers with colorectal cancer is sparse. Feldman (1976 Feldman ( , 1978 collected information on work absences due to a diagnosis of cancer among white collar and blue collar workers. The initial absence from work due to the cancer diagnosis was 6 weeks (median) for white collar DECEMBER 2004, VOL. 52, NO. 12 
What Does This Mean for Workplace Application?
A return to the workplace for cancer survivors represents an important pat~to recovery and restores a sense of normalcy. In addition, the workplace remains a critical resource for cancer survivors because it offers both emotional and financial support long after treatment has ended. Person, disease, and work related barriers can be identified and early intervention provided by remaining in contact with temporarily displaced workers throughout their treatment and recovery period. Consequently, efforts undertaken jointly by employers, oncologists, and occupational health nurses to minimize the barriers to work return can provide survivors with the necessary information to reintegrate back into the workplace. Successful reintegration will be of enormous benefit to survivors, their families, and employers.
workers with colorectal cancer. However, the majority of blue collar workers with colorectal cancer reported their initial absence lasted a minimum of 9 weeks. Studies of workers with cancer in other anatomical sites have reported similar time frames. Watson (1990) found workers with cancer who were employed by AT&T experienced a 60 day absence from the workplace after the initial cancer diagnosis, whereas Bushunow (1995) reported two thirds of workers with breast cancer returned to work within 3 months. More recently, a prospective study showed workers diagnosed with gastrointestinal cancer were at less risk to delay their return to work in comparison to other cancer survivors; however, a specific time frame was not reported (Spelton, 2003) . Unfortunately, it was not possible to ascertain the reasons for the wide variation in the length of time of return (6 weeks to 3 months) from any of these studies because of methodological differences.
Because employment is linked to financial stability and often health insurance coverage, it is important to identify the potential barriers to a timely return to the workplace for cancer survivors. This study assessed the role of person, disease, and work related factors on a timely return to the workplace among employed colorectal cancer survivors who sustained employment 5 years after their initial cancer diagnosis.
METHODS

Study Overview and Participant Recruitment
Colorectal cancer survivors were identified from two population based cancer registries, the Los Angeles County Cancer Surveillance Program (CSP) (Mack, 1977) and the Greater Bay Area Registry located at the Northern California Cancer Center (NCCC). Sample selection involved an oversample of Black (n =143) and Hispanic (n =141) survivors to ensure adequate numbers of survivors from each racial and ethnic group for analytical purposes. A total of 354 White, 143 Black, and 141 Hispanic randomly selected colorectal cancer survivors who were diagnosed from 1994 to 1995, spoke and read English or Spanish, and were between the ages of 30 and 59 at the time of diagnosis were eligible to participate in this study. A 30-minute written survey (in English and Spanish) was sent to the colorectal cancer survivors from April I, 2000 to December 31, 2000. The protocol for the study was approved by the University of Southern California's Institutional Review Board.
Of the 638 potential study subjects, 51 (8%) individuals could not be located, 40 (6%) had died, 35 (5%) individuals did not meet the study eligibility criteria, and 2 individuals were too ill to participate. Of the remaining 510 subjects, 250 (49%) individuals responded to the survey. Reasons for nonparticipation were classified into two groups: active refusal by phone or mail (7%) and passive refusal defined by a "nonretumed" mailing status (44%). Attrition analyses indicated respondents did not differ from the nonrespondents on gender, marital status, age at diagnosis, stage of disease, site of cancer (colon/rectum), year of diagnosis, or by the location of study cases. However, respondents did differ from the nonrespondents by race and ethnicity (p < .00(1). Data indicated Whites were more likely to participate than Blacks and Hispanics, with 58% of eligible Whites compared to 35% of eligible Blacks and 38% of eligible Hispanics responding. Therefore, ethnicity was used as a control variable in the data analyses to correct for this sampling differential.
Survey Measures
Factors selected for measurement in this study were based on the conceptual framework entitled "Pathways to Work Life Recovery." The Pathways to Work Life Recovery framework was derived from the empirical findings of prior return to work studies among cancer survivors (Berry, "1993; Bushunow, 1995; Feldman 1976 Feldman , 1978 Greenleigh Associates, 1979; Sanchez, 200 I; Spelton, 2002; van der Wouden, 1992) . This framework broadly defines three distinct domains yet represents a unified approach that recognizes the interaction of person, disease, and work related factors believed to be influential to return to work experiences.
From a preventive perspective, this conceptual framework categorizes survivor characteristics into amendable and nonamendable groups that could further assist oncologists, occupational health nurses, and social workers in identifying appropriate strategies for future intervention. Within each factor, a logical temporal component (from the time at diagnosis to the posttreatment phase) exists for many of the variables. For example, attitudes toward work during the diagnosis phase may differ compared to work attitudes during the posttreatment phase that may influence the return to work process. The significance of this temporal order has not been empirically established but has the potential to provide insight into the importance of these variables on return to work across time. Use of this framework in this study presumes 502 a logical temporal order with the inclusion of variables measured only at the time of diagnosis to predict barriers to a timely return. Person, disease, and work-related factors were measured.
Person Related Factors. These factors reflect survivor characteristics such as age at diagnosis, gender, race and ethnicity, education, partner status at the time of diagnosis, and whether survivors discussed their decision to return to work with a physician.
Disease Related Factors. These factors assessed information on stage of disease, type of treatment, and use of complementary and alternative medicine therapies.
Work Related Factors. Employment status referenced three points in time: prior to the diagnosis, after diagnosis, and at the time of the survey. The remaining precancer work related factors assessed employment information such as physical demands on the job measured by one item. Respondents were asked the open ended question, "How many hours per week did you work at this job (precancer)?" A dichotomous variable was created based on a cutpoint of 0 to 20 hours representing part-time work status and 21 hours or greater representing fulltime work status. Occupational class information was based on national industry codes and categorized into white collar and service or blue collar.
Health Status. Health status measures at the time of the survey included assessment of physical functioning using the Medical Outcomes Study Short Form (SF-36) subscale (Ware, 199312000) . A cutpoint was based on a median score and was categorized as high functioning versus low functioning. In this sample, the coefficient alpha was .94. The Center for Epidemiological Studies Depression (CES-D) scale (Radloff, 1977) was used to assess the presence of depressive symptoms. A cutoff score of 16 or greater is considered to be the clinical depression standard used in previous community based and cancer populations (Brown, 2003 : Kurtz, 2002 : Ramsey, 2002 Weissman, 1977) . In this sample, the coeflicient alpha was .95. Comorbidity was measured using a list of eight comorbid conditions (chronic sinusitis, arthritis, high blood pressure, deafness, chronic bronchitis, asthma, diabetes, and heart disease) collapsed into a two level comorbidity index (no comorbidity/comorbidity) (Ramsey, 2002 : Satariano, 1996 .
Dependent Variable. The dependent variable was based on the question, "When did you return to work?" The responses were dichotomized as :s:; 2 months compared to > 2 months and recognized as a clinically appropriate time frame. Individuals who indicated they never stopped working were categorized as those who returned in < 2 months. Individuals who did not return to work after cancer treatment were dropped from the analyses.
Data Analysis
Univariate logistic regression analyses were conducted to assess the associations between person, disease, health status, and work related factors and the dependent variable, delay in work return among the survivors. Odds ratios (OR) and confidence intervals (ef) were calculated for each variable found to be statistically significant (p < .05). Confidence intervals that do not contain 1.0 indicate statistical significance. Each independent factor found to be statistically significant at the univariate level was considered for entry into the final multivariate logistic regression model. Before the final logistic model was calculated, a series of correlations were performed to clarify the relationship between the independent variables within the same conceptual area (e.g., socioeconomic status). These analyses helped to reduce the possibility of including duplicate factors in the final model and identified potential variables that might cause multicollinearity problems. The best fitting model was determined by assessing the improvement in the Hosmer and Lemeshow (1989) "goodness of fit" chi-square statistic and R 2 statistic. A good fitting model would yield a high p value (p > .7) for this test, and the R2 statistic describes proportion of the variance in one variable that can be explained by variance in another variable (Cody, 1997; SAS Institute, 1995) .
RESULTS
C%recta/ Cancer Survivorship and Return to Work Experiences
Among the 250 participants, 200 (80%) of the survivors were employed prior to their cancer diagnosis. Among the 50 individuals not employed, 19 (38%) were homemakers, 17 (34%) were unemployed, 12 (24%) were retired at the time of diagnosis, and 2 (4%) were volunteers. Baseline characteristics of the sample strati- fied by their precancer employment status are presented in Table I . Employed survivors differed from unemployed survivors on insurance status (p < .001) and child and domestic responsibilities (p < .05). Stratified by ethnicity, employed Black and Hispanic survivors in this study were more likely to be male (p < .05), report less education (p < .00 I), and experience depressive symptoms (p < .05), and were less likely to be employed in white collar occupations (p < .01) compared to White survivors (see Table 2 ).
Of the 200 survivors who were employed prior to their cancer diagnosis. 177 (89%) returned to work after their cancer diagnosis. Of the 23 survivors who did net return to work, 21 respondents provided the following reasons why they did not return: 9 (42%) did not feel physically able to work, 6 (28%) reported medical reasons for unemployment, 2 respondents indicated their doctor advised against it (10%), 2 (10%) did not want or need to work, and 2 (10%) reported being laid off.
Among the 177 survivors who returned to work, 142 (80%) survivors reported current employment at least 5 years after the cancer diagnosis. This group of survivors held a variety of occupations ranging from professional occupations to unskilled work positions. The majority (60%) of these employed survivors remained at their precancer place of employment.
Factors Associated With a De/ayed Return
Of the 142 currently employed survivors, 51 (36%) returned to the workplace > 60 days following their can- cer diagnosis. In the following analyses, this cutpoint of > 2 months constituted a "delayed return" compared to the survivors in this sample who returned to work in less time.
Person related factors such as age, gender, ethnicity, education, partner status, employment status of partner, and provider communication were not significantly associated with a delayed return to the workplace. However, survivors who were older (age 50 to 59), female, non-White, had a partner, and had completed < 4 years of college were more likely to report a delay in returning to work than their counterparts (see Table 3 ).
Chemotherapy treatment significantly influenced the amount of time taken by survivors to return to work. Survivors who received chemotherapy were three times more likely to delay their return to work beyond 2 months of the diagnosis compared to those who did not receive such treatment (OR =3.40, CI = 1.60 to 7.24).
The remaining disease related factors did not reach statistical significance (see Table 4 ).
Survivors in blue collar or service occupations, those in jobs that required heavy lifting, and those employed < 506 20 hours per week were more likely to delay returning to work in comparison to their counterparts. However, the magnitude of these findings was small and not statistically significant (see Table 5 ).
Multivariate Model
To account for unmeasured differences in the sample related to socioeconomic status and comorbidity related to the diagnosis, education and stage of disease were controlled for. An initial correlation analyses revealed significant correlations between ethnicity and these two study variables. Non-White survivors were more likely to be diagnosed with late stage cancer compared to White survivors (r= .17,p = .04). In addition, non-White survivors were more likely to report less education compared to White survivors (r = .19, p =.02). Consequently, two interaction terms (ethnicity and stage, ethnicity and education) were created and included in the final logistic model. The full multivariate model consisted of the following variables: ethnicity, education, disease severity, chemotherapy treatment, and two interaction terms. The multivariate analyses indicated the receipt of chernother- apy treatment (OR =3.41, Cl =1.53 to 7.58) remained a significant predictor of survivors returning to work> 2 months. The remaining variables and the two interaction terms did not reach statistical significance in the multivariate model. The full model explained 10% of the variance in work delay and resulted in a chi square of 1.41 and a p value of .97, an indication of a good fit.
DISCUSSION
Return to Work Experiences
A diagnosis of cancer profoundly impacts not only individuals and their families, but also the work force in general because it results in a significant number of displaced workers. The data revealed the majority of the cancer survivors in this study have been successful in their attempt to return to the workplace. The 89% rate of work return observed among this group of colorectal cancer survivors was a noticeable improvement from the 75% rate reported by Feldman (1976 Feldman ( , 1978 in two studies of colorectal cancer patients. This preliminary finding is encouraging for survivors who are physically able to return to work. Of those who did not return, the majority (80%) did not return for health and medical reasons. This finding is consistent with data presented by Hewitt (2003) that indicated survivors with multiple comorbid conditions increased the likelihood of having a work limitation or disability compared to survivors without comorbidity, In contrast, for workers who returned but are not currently employed, they seemed to do so out of DECEMBER 2004, VOL. 52. NO. 12 personal choice (i.e., retirement).
Among those who returned to work, 60% of the survivors returned to their precancer place of employment. This finding represents a decrease from the 79% observed by Feldman (1978) more than 25 years ago. This finding suggests perhaps "job lock" is currently less of a problem than in the past, enabling survivors to change jobs freely without fear of losing monetary and health insurance benefits. Alternatively, the data might reflect unknown, cancer related circumstances that compelled survivors to leave their precancer workplace.
The majority (80%) of colorectal cancer survivors who returned to work after diagnosis in this study reported employment approximately 6 years later. This preliminary finding is slightly higher than the return to work rate of 67% among colon cancer survivors documented by Schultz (2002) . Prior studies are not comparable because the majority of the studies (Bradley, 2002; Bushunow, 1995; Feldman 1976 Feldman , 1978 Greenleigh Associates, 1979; Satariano, 1996; Spelton, 2003; Watson, 1990 ) focused on survivors 2 years following their initial cancer diagnosis or the return to work rate was not reported specifically for colorectal cancer survivors. The finding in the present study may be explained by the mean age of survivors (48 years) and the high degree of wellness in this particular group of cancer survivors.
Factors Associated With a Delayed Return
The data revealed 64% of the employed survivors returned to work within 2 months following their cancer diagnosis. Given this, it would be reasonable to speculate that employed survivors who returned later than 2 months may have encountered difficulties. These difficulties may have been associated with cancer related symptoms such as fatigue. Empirical data suggest survivors who reported feelings of fatigue were 2.5 times more likely to delay their return to work than survivors who experienced little or no symptoms of fatigue (Spelton, 2003) . If this assertion is true, then the identification and resolution of these difficulties by occupational health nurses and oncologists could be of enormous benefit to survivors who desire to return to work. Alternatively, this delayed return may reflect survivors' deliberate choice or reflect a degree of flexibility in their circumstances. In this study, chemotherapy treatment played a role in delay, suggesting this outcome may not have been a deliberate choice entirely. Further investigation is needed to assess what time interval constitutes an expected return and what type of delay constitutes "at risk" survivors. Within this sample, a disease related factor (chemotherapy) appeared to have a greater impact on predicting work delay than person or work related factors. The study's limited sample size and composition hinders any definitive conclusions, yet further exploration is warranted. Delays in work return could affect job availability, wages, and health insumnce coverage, with the greatest impact on groups historically known to have lower wages and employment rates. Guidry (1998) observed Black (46%) cancer clients were more likely to report a loss of health insurance coverage postdiagnosis than Hispanics (28%) and Whites (26%). Although Guidry did not elaborate on whether insurance loss was tied to work return, the data revealed racial and ethnic disparities in insurance coverage on changing jobs. The consequences of work delay can be far reaching, and efforts to reduce this delay 508 by talking with colorectal cancer patients about their insurance benefits and work life may improve the quality of life of economically disadvantaged cancer survivors.
Chemotherapy treatment remained a significant predictor of work delay after controlling for ethnicity, education, and severity of disease. However, the amount of variance of work delay as a result of chemotherapy suggests there are other unmeasured factors (i.e., cancer related symptoms) contributing to work delay. In addition, it is unclear from the data whether the side effects of chemotherapy treatment (i.e., fatigue) were responsible for the delay or whether the time period of survivors' treatment regimens, extended beyond a 2 month period, may have necessitated the delay. However, this effect was not diminished when the cutpoint of 2 months (representative of 64%) was extended to 5 months (representative of 81% of the sample). If delay is related to chemotherapy, oncologists and primary care providers can identify and modify problem situations with a focus on minimizing side effects, providing support care services to manage a chemotherapy regimen in the workplace, and encouraging financial counseling to anticipate and mitigate a reduction in earnings for those who must delay their return.
The impact of chemotherapy treatment on work outcomes has been studied among breast cancer patients. Meyerowitz (1983) found 45% of women experience work changes, including leaving the workplace, attributed to the effects of adjuvant chemotherapy. In contrast, Bushunow (1995) observed chemotherapy did not cause a delay in work return among breast cancer patients. However, in the Bushunow (1995) study, the definition of delay was~12 months.
Surprisingly, surgery did not contribute to work delay in this study. There were no statistically significant differences between survivors who had chemotherapy compared to those who did not. Survivors who had chemotherapy in this study shared a similar profile to the larger sample.
STUDY LIMITATIONS
The findings of this study should be interpreted within the scope of the limitations in design, measurement, and sampling. The cross sectional nature of the study design does not provide conclusive evidence that the identified disease related factor (chemotherapy) was a causal agent in delaying a return to work. Second, the data on employment and social support were self reported and might not fully reflect family and workplace characteristics. Likewise, retrospective information on either precancer work experience or the current return to work experience may reflect some recall bias. Finally, the study participation rate was low, which limits the generalizability of these findings. Participants were predominantly White, well educated colorectal cancer survivors who were in good physical and mental heahh for the most part. The rate of employment, return to work, and current employment observed in this study might be different with the inclusion of greater numbers of Black and Hispanic survivors. Nevertheless, the small sample of employed Black and Hispanic survivors did provide important clues on work issues and prevalence of depressive symptoms to be explored in larger studies. It is believed these limitations do not diminish the value of the information to occupational health nurses, oncology researchers, and practitioners that may be derived from this exploratory study. In the context of these limitations, the findings add a new dimension of knowledge to the existing foundation of quality of life research and provide insights on the impact of a cancer history on work life. Future studies that can follow colorectal cancer survivors prospectively to document barriers to work return will inform the design of interventions and occupational services directed at keeping survivors healthy and in the workplace. Approval of educational activities by AAOHN:
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